Results 191 to 200 of about 394,456 (275)

A Vaccine to Prevent Congenital Cytomegalovirus: Where Do We Go Next? [PDF]

JAMA Pediatr
Schleiss MR, Plotkin SA, Permar SR.
europepmc   +1 more source

Updated profiling of COVID-19 vaccine adverse events using VAERS case reports. [PDF]

Front Pharmacol
He A, Hur K, Li X, Zheng J, Hur J, He Y.
europepmc   +1 more source

Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345, an mRNA Vaccine Against Respiratory Syncytial Virus, Administered 12 Months Following a Primary Dose in Adults Aged ≥50 Years. [PDF]

Clin Infect Dis
Goswami J, Cardona JF, Caso J, Hsu DC, Simorellis AK, Wilson L, Dhar R, Wang X, Kapoor A, Collins A, Righi V, Lan L, Du J, Zhou H, Stoszek SK, Shaw CA, Reuter C, Wilson E, Das R.   +18 more
europepmc   +1 more source

The clinical impact of bronchoscopy: balancing microbiology and inflammatory endotyping. [PDF]

ERJ Open Res
De Angelis A, Simonetta E, Scarano P, Tramontano A, Nigro M, Lo Casto M, Mancuso M, Polelli V, Battaglia S, Crimi C, Sibila O, Chalmers JD, Blasi F, Aliberti S.   +13 more
europepmc   +1 more source

Comparative Effectiveness of mRNA-1273 Versus Protein-Based NVX-CoV2705 Vaccination on COVID-19-Related Outcomes Among Insured Adults in the United States During 2024-2025: A Retrospective Matched Cohort Study. [PDF]

Adv Ther
Wilson A, Beck E, Hensler H, Vicic N, Joshi K, Patry E, Li L, Wang J, Clarke C.   +8 more
europepmc   +1 more source

Study Designs for INTerpath-002 and INTerpath-009 of Adjuvant Intismeran Autogene Plus Pembrolizumab for Non-Small Cell Lung Cancer. [PDF]

Ann Thorac Surg Short Rep
Spicer JD, Peters S, Gainor JF, Chaft JE, Bestvina CM, Lee JM, Marron TU, Khattak MA, Ojalvo LS, Banerjee JK, Wang Z, Deng X, Shariati N, Keller SM, Cascone T.   +14 more
europepmc   +1 more source

First Report on Remdesivir Use for the Treatment of Respiratory Syncytial Virus in Five Allogeneic Hematopoietic Cell Transplant Recipients. [PDF]

J Infect Dis
McCulloch DJ, Khawaja F, Tverdek FP, Ford ES, Vora SB, Waghmare A, Vuong N, Chemaly RF, Hill JA.   +8 more
europepmc   +1 more source

Safety and Immunogenicity of the Cytomegalovirus Vaccine mRNA-1647 in Healthy Adults: Results from a Phase 2, Randomized, Controlled, Dose-Finding Trial with Long-Term Extension Follow-Up Through Month 48. [PDF]

Vaccines (Basel)
Fierro C, Brune D, Leggett R, Peterson J, Lorenz B, Calabro Calheiros R, Lin J, Iyer AS, Wu K, Cao X, Kondapally A, Marsh S, Kalidindi S, Husson J, Panther L.   +14 more
europepmc   +1 more source

Economic Burden of RSV-Associated Hospitalizations in Switzerland: A Nationwide Analysis (2017-2023). [PDF]

Healthcare (Basel)
Boesing M, McCarthy-Pontier D, Leuppi JD, Kräutler NJ.   +3 more
europepmc   +1 more source